Drug Type Small molecule drug |
Synonyms ID 11905, ID-11905, ID119050134 |
Target |
Action inhibitors |
Mechanism autotaxin inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glaucoma | Preclinical | South Korea | 19 Feb 2024 | |
| Liver Cirrhosis | Preclinical | South Korea | 21 Sep 2023 | |
| Gastroesophageal Reflux | Preclinical | South Korea | - | |
| Nonalcoholic Steatohepatitis | Preclinical | South Korea | - |





